Asia Pacific Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Deliv

Asia Pacific Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others)

The bioresorbable polymers market in Asia Pacific is expected to grow from US$ 782.77 million in 2021 to US$ 1,697.06 million by 2028; it is estimated to grow at a CAGR of 11.7% from 2021 to 2028.

The growing number of road and work-related accidents is one of the key factors contributing to the increased demand for orthopedic surgeries in this region. Road and work-related accidents may cause multiple fractures, joint dislocation, ligament damage, and broken bones at several body parts, requiring orthopedic implants to heal and cure the injuries. Bioresorbable polymer-based implants are being widely used for fracture fixation in orthopedic surgeries. Orthopedic implants such as interference screws, plates, pins, suture anchors, and meniscal repair implants as well as simple fracture fixation implants are the most commonly used resorbable implants for anterior cruciate ligament reconstruction, shoulder surgery, meniscal repair, and fracture care. Once the desired function is served, these implants dissolve in the body by themselves during the healing and nurturing process.

The ongoing COVID-19 pandemic is anticipated to cause considerable disruptions in the growth of various industries of Asia Pacific. However, the uncertainty regarding future outbreaks, especially in countries such as India and a few other Asian countries, has altered the status of several industrial sectors. The governments of various Asia Pacific countries have taken possible steps to restrict the spread of SARS-Co V-2. The country-wide lockdown enacted by them directly impacted the growth of various industries due to the subsequent shutdown of manufacturing units and disruptions in the supply chains. In India, there has been a reduction in road accidents during the COVID pandemic. According to the Minister for Road Transport and Highways, there was a 26.48% decrease in road accidents. As a result, there was a low need for tissue engineering operations, which hampered the demand for medical implants, thus hindering the bioresorbable polymer market growth in the country.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific bioresorbable polymers market at a good CAGR during the forecast period.

Asia Pacific Bioresorbable Polymers Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Bioresorbable Polymers Market Segmentation

Asia Pacific Bioresorbable Polymers Market - by Type

Polylactic Acid (Pla) Polyglycolic Acid (Pga) Polydioxanone Polycaprolactone(Pcl) Others Asia Pacific Bioresorbable Polymers Market - by Application

Orthopedic Devices Drug Delivery Other Application Asia Pacific Bioresorbable Polymers Market - by Country

Australia China India Japan South Korea Rest of APACAsia Pacific Bioresorbable Polymers Market - Companies Mentioned

Evonik Industries AG Musashino Chemical Laboratory, Ltd. Ashland Global Holdings Inc. Poly-Med Incorporated Foster Corporation BMG Incorporated Huizhou Foryou Medical Devices Co., Ltd. Polysciences Inc. Bezwada Biomedical LLC

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific bioresorbable polymers market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioresorbable polymers market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the bioresorbable polymers market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution